C. Gilks

发表

Subtype‐specific mutation of PPP2R1A in endometrial and ovarian carcinomas

A. Mes-Masson, S. Shah, D. Huntsman, 2011, The Journal of pathology.

Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss

Matt van de Rijn, George Coukos, Dmitry Turbin, 2009, Modern Pathology.

Human epidermal growth factor receptor 2 testing in primary breast cancer in the era of standardized testing: a Canadian prospective study.

C. Gilks, A. Magliocco, S. Nofech-Mozes, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemotherapy Response Score: Development and Validation of a System to Quantify Histopathologic Response to Neoadjuvant Chemotherapy in Tubo-Ovarian High-Grade Serous Carcinoma.

A. Tinker, N. Le, C. Gilks, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Interpretation of P53 Immunohistochemistry in Endometrial Carcinomas: Toward Increased Reproducibility

M. Köbel, C. Gilks, Naveena Singh, 2018, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 1 Fit-for-Purpose Approach to Classification of Clinical Immunohistochemistry Biomarkers

Clive R. Taylor, Jacqueline A. Hall, A. Marchetti, 2017, Applied immunohistochemistry & molecular morphology : AIMM.

Letter to the editor regarding ‘Roh MH, Lassin Y, Miron A et al. High-grade fimbrial-ovarian carcinomas are unified by p53, PTEN and PAX2 expression’

M. Köbel, B. Clarke, C. Gilks, 2011, Modern Pathology.

Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior.

C. Gilks, M. Merino, B. Werness, 2004, Human pathology.

Markers of Proliferative Activity Are Predictors of Patient Outcome for Low-Grade Endometrioid Adenocarcinoma But Not Papillary Serous Carcinoma of Endometrium

C. Gilks, C. Aquino-Parsons, P. Lim, 2002, Modern Pathology.

Fit-For-Purpose PD-L1 Biomarker Testing For Patient Selection in Immuno-Oncology: Guidelines For Clinical Laboratories From the Canadian Association of Pathologists-Association Canadienne Des Pathologistes (CAP-ACP)

C. Gilks, M. Tsao, C. Cheung, 2019, Applied immunohistochemistry & molecular morphology : AIMM.

Adenomyomas of the uterine cervix of of endocervical type: a report of ten cases of a benign cervical tumor that may be confused with adenoma malignum [corrected].

P. Clement, C. Gilks, R. Scully, 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Surgical staging of early stage epithelial ovarian cancer.

D. Huntsman, C. Gilks, 2011, Gynecologic Oncology.

Recurrent endometrial adenocarcinoma: presentation as a splenic mass mimicking malignant lymphoma.

P. Clement, C. Gilks, B. Acker, 1989, Gynecologic oncology.

Disease Distribution in Low-stage Tubo-ovarian High-grade Serous Carcinoma (HGSC): Implications for Assigning Primary Site and FIGO Stage

M. Anglesio, C. Gilks, Naveena Singh, 2017, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

The Histomorphology of Lynch Syndrome–associated Ovarian Carcinomas: Toward a Subtype-specific Screening Strategy

W. Foulkes, B. Clarke, J. Kwon, 2014, The American journal of surgical pathology.

Identifying Lynch Syndrome in Patients With Ovarian Carcinoma: The Significance of Tumor Subtype

B. Clarke, C. Gilks, M. Chui, 2013, Advances in anatomic pathology.

Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 4 Tissue Tools for Quality Assurance in Immunohistochemistry

Clive R. Taylor, Jacqueline A. Hall, A. Marchetti, 2017, Applied immunohistochemistry & molecular morphology : AIMM.

Academic and nonacademic laboratories perform equally on CIQC immunohistochemistry proficiency testing.

C. Gilks, E. Torlakovic, H. Neufeld, 2013, American journal of clinical pathology.

Vulval squamous cell carcinoma and its precursors

C. Gilks, Naveena Singh, N. Singh, 2020, Histopathology.

Expanding the Morphologic Spectrum of Differentiated VIN (dVIN) Through Detailed Mapping of Cases With p53 Loss

J. McAlpine, C. Gilks, Naveena Singh, 2015, The American journal of surgical pathology.

Uterine Adenomyomas Excluding Atypical Polypoid Adenomyomas and Adenomyomas of Endocervical Type: A Clinicopathologic Study of 30 Cases of an Underemphasized Lesion That May Cause Diagnostic Problems with Brief Consideration of Adenomyomas of Other Female Genital Tract Sites

P. Clement, C. Gilks, R. Young, 2000, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

cervical mucins . assessing cyclical changes in glycoproteins : its use in acidic sugars in mucin relative quantities of neutral and Simple procedure for assessing

P. Clement, C. Gilks, D. Owen, 2005 .

Histochemical changes in cervical mucus-secreting epithelium during the normal menstrual cycle.

P. Clement, C. Gilks, D. Owen, 1989, Fertility and sterility.

Simple procedure for assessing relative quantities of neutral and acidic sugars in mucin glycoproteins: its use in assessing cyclical changes in cervical mucins.

P. Clement, C. Gilks, D. Owen, 1988, Journal of clinical pathology.

Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts.

Stefano Monti, Giovanni Parmigiani, Matthew Meyerson, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype

D. Huntsman, M. Köbel, Erika Mehl, 2009, Modern Pathology.

Molecular subclassification of vulvar squamous cell carcinoma: reproducibility and prognostic significance of a novel surgical technique

J. Senz, J. McAlpine, C. Gilks, 2022, International Journal of Gynecological Cancer.

Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation‐positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries

B. Clarke, S. Kalloger, J. Kwon, 2012, Cancer.

A comparison of p53 and WT1 immunohistochemical expression patterns in tubo‐ovarian high‐grade serous carcinoma before and after neoadjuvant chemotherapy

M. Köbel, C. Gilks, Naveena Singh, 2017, Histopathology.

Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data.

Yun Yi Tan, A. Tinker, N. Le, 2019, Gynecologic oncology.

Large cell neuroendocrine [corrected] carcinoma of the uterine cervix: a clinicopathologic study of 12 cases.

P. Clement, C. Gilks, R. Young, 1997, The American journal of surgical pathology.

Terminology of endocrine tumors of the uterine cervix: results of a workshop sponsored by the College of American Pathologists and the National Cancer Institute.

L. Sobin, W. Travis, C. Gilks, 1997, Archives of pathology & laboratory medicine.

Deep learning-based histotype diagnosis of ovarian carcinoma whole-slide pathology images

A. Bashashati, D. Huntsman, M. Köbel, 2022, Modern Pathology.

Mucinous Tumors of the Appendix Associated With Mucinous Tumors of the Ovary and Pseudomyxoma Peritonei: A Clinicopathological Analysis of 22 Cases Supporting an Origin in the Appendix

C. Gilks, R. Scully, R. Young, 1991, The American journal of surgical pathology.

Protocol for the Examination of Specimens From Patients With Carcinoma of the Endometrium

C. Gilks, P. Branton, E. Oliva, 2009 .

Proteomic Analysis of Transitional Cell Carcinoma-Like Variant of Tubo-Ovarian High-Grade Serous Carcinoma.

Christopher S. Hughes, A. Talhouk, S. Leung, 2020, Human pathology.

Assessment of CK17 as a Marker for the Diagnosis of Differentiated Vulvar Intraepithelial Neoplasia

C. Gilks, Naveena Singh, M. Sanders, 2017, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Adenoma Malignum (Minimal Deviation Adenocarcinoma) of the Uterine Cervix: A Clinicopathological and Immunohistochemical Analysis of 26 Cases

C. Gilks, R. Scully, R. Young, 1989, The American journal of surgical pathology.

Data Set for the Reporting of Carcinomas of the Vulva: Recommendations From the International Collaboration on Cancer Reporting (ICCR)

C. Gilks, Naveena Singh, J. Ordi, 2022, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Data Set for the Reporting of Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma: Recommendations From the International Collaboration on Cancer Reporting (ICCR).

M. Köbel, C. Gilks, J. Ledermann, 2022, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Development of an evidence-based approach to external quality assurance for breast cancer hormone receptor immunohistochemistry: comparison of reference values.

C. Gilks, R. Alaghehbandan, E. Torlakovic, 2011, Archives of pathology & laboratory medicine.

Uterine Serous Carcinomas Frequently Metastasize to the Fallopian Tube and Can Mimic Serous Tubal Intraepithelial Carcinoma

C. Gilks, Naveena Singh, W. McCluggage, 2017, The American journal of surgical pathology.

Borderline Ovarian Mucinous Tumors : Consensus Points and Persistent Controversies Regarding Nomenclature , Diagnostic Criteria , and Behavior

C. Gilks, M. Merino, R. Young, 2005 .

HPV-independent, p53-wild-type vulvar intraepithelial neoplasia: a review of nomenclature and the journey to characterize verruciform and acanthotic precursor lesions of the vulva

C. Gilks, Naveena Singh, M. Nucci, 2022, Modern Pathology.

Serous psammocarcinoma of the ovary and peritoneum.

C. Gilks, R. Scully, D. Bell, 1990, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Practical Guidance for Measuring and Reporting Surgical Margins in Vulvar Cancer

C. Gilks, Naveena Singh, K. K. van de Vijver, 2019, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Immunophenotypic features of dedifferentiated endometrial carcinoma – insights from BRG1/INI1‐deficient tumours

M. Köbel, C. Gilks, B. Tessier-Cloutier, 2016, Histopathology.

Gene expression patterns and gene copy number changes in dermatofibrosarcoma protuberans.

David Botstein, Tina Hernandez-Boussard, David Siegmund, 2003, The American journal of pathology.

Deep learning-based histotype diagnosis of ovarian carcinoma whole-slide pathology images

A. Bashashati, D. Huntsman, M. Köbel, 2022, Modern Pathology.

Idiopathic granulomatous mastitis. A report of three cases and review of the literature.

C. Gilks, W. Donn, C. Wilson, 1994, Archives of pathology & laboratory medicine.

Luteinized thecomas (thecomatosis) associated with sclerosing peritonitis exhibit positive staining with sex cord markers steroidogenic factor-1 (SF-1) and FOXL2.

P. Clement, C. Gilks, R. Young, 2013, The American journal of surgical pathology.

Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomes

Christopher S. Hughes, T. Nielsen, G. Morin, 2022, Nature Communications.

Long-Term Responders on Olaparib Maintenance in High-Grade Serous Ovarian Cancer: Clinical and Molecular Characterization

E. Kohn, D. Bowtell, A. Oza, 2017, Clinical Cancer Research.

HMGA2 is commonly expressed in uterine serous carcinomas and is a useful adjunct to diagnosis

S. Kalloger, C. Gilks, W. McCluggage, 2012, Histopathology.

ARID1A loss correlates with mismatch repair deficiency and intact p53 expression in high-grade endometrial carcinomas

B. Clarke, S. Kalloger, C. Gilks, 2014, Modern Pathology.

Carcinomas With Concurrent Involvement of the Endometrium and Uterine Adnexa—Implications for Pathological Diagnosis and Clinical Management in Current Practice

A. Tinker, C. Gilks, N. Singh, 2022, AJSP: Reviews and Reports.

Key changes to the World Health Organization (WHO) classification of female genital tumours introduced in the 5th edition (2020)

C. Gilks, W. McCluggage, N. Singh, 2022, Histopathology.

The changing landscape of gynaecological cancer diagnosis: implications for histopathological practice in the 21st century

C. Gilks, N. Singh, 2017, Histopathology.

The secondary Müllerian system, field effect, BRCA, and tubal fimbria: our evolving understanding of the origin of tubo-ovarian high-grade serous carcinoma and why assignment of primary site matters

C. Gilks, W. McCluggage, N. Wilkinson, 2015, Pathology.

Assignment of primary site in high‐grade serous tubal, ovarian and peritoneal carcinoma: a proposal

C. Gilks, W. McCluggage, N. Wilkinson, 2014, Histopathology.

Ovarian carcinoma histotype determination is highly reproducible, and is improved through the use of immunohistochemistry

M. Köbel, C. Gilks, O. Carpén, 2014, Histopathology.

Differential diagnosis and clinical relevance of ovarian carcinoma subtypes

C. Gilks, C. Conklin, C. Gilks, 2013 .

Calculator for ovarian carcinoma subtype prediction

S. Leung, D. Huntsman, M. Köbel, 2011, Modern Pathology.

Tumor type and substage predict survival in stage I and II ovarian carcinoma: insights and implications.

D. Huntsman, M. Köbel, S. Kalloger, 2010, Gynecologic oncology.

Applications of microarrays to histopathology

M. van de Rijn, C. Gilks, C. Gilks, 2004, Histopathology.

Critical molecular abnormalities in high-grade serous carcinoma of the ovary

D. Huntsman, M. Köbel, C. Gilks, 2008, Expert Reviews in Molecular Medicine.

L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile

A. Talhouk, D. Huntsman, C. Gilks, 2018, British Journal of Cancer.

Nonneoplastic Lesions of the Ovary

C. Gilks, T. Longacre, 2020, Gynecologic Pathology.

Kruppel-like factor 5 is not required for K-RasG12D lung tumorigenesis, but represses ABCG2 expression and is associated with better disease-specific survival.

C. Gilks, J. Whitsett, Yan Xu, 2010, The American journal of pathology.

Diagnostic Accuracy in Fit-for-Purpose PD-L1 Testing

Jennifer Won, John Garratt, Carol C Cheung, 2019, Applied immunohistochemistry & molecular morphology : AIMM.

Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine. Part 3: Technical Validation of Immunohistochemistry (IHC) Assays in Clinical IHC Laboratories

Jacqueline A. Hall, A. Marchetti, M. Dietel, 2017, Applied immunohistochemistry & molecular morphology : AIMM.

Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine - Part 2: Immunohistochemistry Test Performance Characteristics.

Keith Miller, Clive R Taylor, Manfred Dietel, 2017, Applied immunohistochemistry & molecular morphology : AIMM.

Canadian Association of Pathologists-Association canadienne des pathologistes National Standards Committee for High Complexity Testing/Immunohistochemistry: guidelines for the preparation, release, and storage of unstained archived diagnostic tissue sections for immunohistochemistry.

B. Clarke, C. Gilks, C. Cheung, 2014, American journal of clinical pathology.

Implementation of a Canadian External Quality Assurance Program for Breast Cancer Biomarkers: An Initiative of Canadian Quality Control in Immunohistochemistry (cIQc) and Canadian Association of Pathologists (CAP) National Standards Committee/Immunohistochemistry

Richard Berendt, Louis Gaboury, Anthony Magliocco, 2009, Applied immunohistochemistry & molecular morphology : AIMM.

High‐grade serous carcinoma of tubo‐ovarian origin: recent developments

C. Gilks, W. McCluggage, N. Singh, 2017, Histopathology.

Adult granulosa cell tumour‐like areas occurring in ovarian epithelial neoplasms: report of a case series with investigation of FOXL2 mutation status

D. Huntsman, C. Gilks, W. McCluggage, 2014, Histopathology.

Well-differentiated Sertoli-Leydig Cell Tumors (SLCTs) Are Not Associated With DICER1 Pathogenic Variants and Represent a Different Tumor Type to Moderately and Poorly Differentiated SLCTs

W. Foulkes, B. Clarke, C. Gilks, 2022, The American journal of surgical pathology.

Better therapeutic trials in ovarian cancer.

E. Kohn, A. Oza, D. Huntsman, 2014, Journal of the National Cancer Institute.

Better t herapeutic t rials in ovarian Cancer

C. Gilks, M. Bookman, 2014 .

Molecular abnormalities in ovarian carcinoma: clinical, morphological and therapeutic correlates

C. Gilks, Tawny Hung, J. Morin, 2013, Histopathology.

Preclinical Evaluation of a Fluorescent Probe Targeting Receptor CDCP1 for Identification of Ovarian Cancer.

Nicholas J. Lyons, C. Gilks, T. Munro, 2021, Molecular pharmaceutics.

Identification of prognostically relevant and reproducible subsets of endometrial adenocarcinoma based on clustering analysis of immunostaining data

Matt van de Rijn, David Huntsman, Anthony Magliocco, 2007, Modern Pathology.

Progesterone receptor expression is associated with longer overall survival within high-grade histotypes of endometrial carcinoma: A Canadian high risk endometrial cancer consortium (CHREC) study.

M. Köbel, B. Clarke, J. McAlpine, 2016, Gynecologic oncology.

Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays.

Ash A. Alizadeh, Yasodha Natkunam, Kelli Montgomery, 2002, The American journal of pathology.

The Fallopian Tube Origin and Primary Site Assignment in Extrauterine High-grade Serous Carcinoma: Findings of a Survey of Pathologists and Clinicians

C. Gilks, W. McCluggage, L. Hirschowitz, 2017, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type

B. Clarke, C. Gilks, C Blake Gilks, 2010, Journal of Clinical Pathology.

Assessment of a new system for primary site assignment in high‐grade serous carcinoma of the fallopian tube, ovary, and peritoneum

C. Gilks, W. McCluggage, N. Wilkinson, 2015, Histopathology.

p16 Immunostaining Allows for Accurate Subclassification of Vulvar Squamous Cell Carcinoma Into HPV-Associated and HPV-Independent Cases

J. McAlpine, C. Gilks, S. Jordan, 2016, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Patterns of p53 immunoreactivity in endometrial carcinomas: ‘all or nothing’ staining is of importance

C Blake Gilks, C. Gilks, R. Soslow, 2011, Histopathology.

Mixed Ovarian Epithelial Carcinomas With Clear Cell and Serous Components are Variants of High-grade Serous Carcinoma: An Interobserver Correlative and Immunohistochemical Study of 32 Cases

S. Leung, C. Gilks, T. Longacre, 2008, The American journal of surgical pathology.

Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)

M. Köbel, B. Clarke, C. Gilks, 2015, Modern Pathology.

Cyclical expression of the DNA mismatch repair enzyme hMLH1 in normal endometrium.

C. Gilks, J. Irving, B. Dupuis, 2002, Fertility and sterility.

Lynch syndrome screening in gynaecological cancers: results of an international survey with recommendations for uniform reporting terminology for mismatch repair immunohistochemistry results

C. Gilks, T. Bosse, M. Arends, 2019, Histopathology.

Targeted Molecular Testing in Endometrial Carcinoma: Validation of a Clinically Driven Selective ProMisE Testing Protocol

A. Talhouk, S. Leung, J. McAlpine, 2022, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Interpretation of mismatch repair protein expression using obsolete criteria results in discrepancies with microsatellite instability and mutational testing results. Comment on Hechtman et al. Mod Pathol 2020; 33:871–879

B. Clarke, C. Gilks, R. Wong, 2020, Modern Pathology.

Histopathological features of endometrial carcinomas associated with POLE mutations: implications for decisions about adjuvant therapy

M. Köbel, J. McAlpine, C. Gilks, 2016, Histopathology.

Minichromosome maintenance protein 7 as a potential prognostic factor for progression-free survival in high-grade serous carcinomas of the ovary

L. Hartmann, C. Gilks, A. Clayton, 2011, Modern Pathology.

Immunohistochemical characterization of prototypical endometrial clear cell carcinoma—diagnostic utility of HNF‐1β and oestrogen receptor

D. Huntsman, M. Köbel, C. Chow, 2014, Histopathology.

231 Molecular subclassification of vulvar squamous cell carcinoma: prognostic significance and reproducibility

J. Senz, C. Gilks, J. Huvila, 2021, Vaginal and vulvar cancer.

Reply to Comment on HPV-independent, p53-Wild-type Vulvar Intraepithelial Neoplasia: A Review of Nomenclature and the Journey to Characterize Acanthotic Precursor Lesions of the Vulva.

C. Gilks, M. Nucci, T. Bosse, 2023, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Differential expression of cell-cycle regulatory proteins defines distinct classes of follicular lymphoma.

H. Feilotter, A. Day, C. Gilks, 2011, Human pathology.

Evaluation of immunohistochemical markers in non‐small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markers

A Coldman, D. Huntsman, E. Yorida, 2004, The Journal of pathology.

HER2/neu testing in gastric cancer by immunohistochemistry: assessment of interlaboratory variation.

S. Kalloger, C. Gilks, E. Torlakovic, 2014, Archives of pathology & laboratory medicine.

Inflammatory pseudotumor of the uterus.

P. Clement, C. Gilks, G. P. Taylor, 1987, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Primary site assignment in tubo-ovarian high-grade serous carcinoma: Consensus statement on unifying practice worldwide.

Dianne Miller, C. Gilks, S. Kehoe, 2016, Gynecologic oncology.

Loss of p16 INK4 expression in invasive squamous cell carcinoma of the uterine cervix is an adverse prognostic marker

C. Gilks, M. Cheang, K. Bilek, 2006, Histopathology.

Trichoblastic Fibroma A Clinicopathologic Study of Three Cases

P. Clement, C. Gilks, W. Wood, 1989, American journal of dermatopathology.

Molecular subtyping of mammary‐like adenocarcinoma of the vulva shows molecular similarity to breast carcinomas

A. Tinker, C. Gilks, B. Tessier-Cloutier, 2017, Histopathology.

Screening for urothelial malignancies by cytologic analysis and flow cytometry in a community urologic practice: a prospective study.

C. Gilks, V. Chan, W. Gourlay, 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Adopting a Uniform Approach to Site Assignment in Tubo-Ovarian High-Grade Serous Carcinoma: The Time has Come.

Naveena Singh, C. Blake Gilks, Lynn Hirshowitz, 2016, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

The continuing evolution of endometrial carcinoma molecular classification: Risk stratification within the No Specific Molecular Profile (NSMP) subtype.

J. McAlpine, C. Gilks, J. Huvila, 2023, Gynecologic oncology.

Commentary: novel observations and detailed molecular characterisation of mixed tumours and mesonephric‐like carcinosarcomas by Mirkovic et al. (2023)

C. Gilks, Jennifer Pors, L. Hoang, 2023, Histopathology.

Thyroid transcription factor‐1 (TTF‐1) immunoreactivity is an adverse prognostic factor in endometrioid adenocarcinoma of the uterine corpus

S. Leung, C. Gilks, C. Gilks, 2014, Histopathology.

The changing landscape of gynaecological pathology: WHO 2020 and beyond

C. Gilks, N. Singh, 2020, Histopathology.

QPOLE: A Quick, Simple, and Cheap Alternative for POLE Sequencing in Endometrial Cancer by Multiplex Genotyping Quantitative Polymerase Chain Reaction

J. Khattra, J. McAlpine, C. Gilks, 2023, JCO global oncology.

Pathology of Gynecologic Cancers

C. Gilks, 2015 .

Extrauterine high-grade serous carcinomas with bilateral adnexal involvement as the only two disease sites are clonal based on tp53 sequencing results: implications for biology, classification, and staging

J. Senz, M. Anglesio, C. Gilks, 2017, Modern Pathology.

Intratumoral oxygenation of invasive squamous cell carcimoma of the vulva is not correlated with regional lymph node metastasis.

C. Gilks, E. Stanbridge, C. Aquino-Parsons, 2005, European journal of gynaecological oncology.

Ovarian carcinoma pathology and genetics: recent advances.

C. Gilks, C. Gilks, J. Prat, 2009, Human pathology.

The Chemotherapy Response Score (CRS): Interobserver Reproducibility in a Simple and Prognostically Relevant System for Reporting the Histologic Response to Neoadjuvant Chemotherapy in Tuboovarian High-grade Serous Carcinoma

C. Gilks, W. McCluggage, S. Böhm, 2016, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Endometrial carcinoma: molecular subtypes, precursors and the role of pathology in early diagnosis

C. Gilks, C. Gilks, E. Thompson, 2020, The Journal of pathology.

Advanced-Stage Serous Borderline Tumors of the Ovary: A Clinicopathological Study of 49 Cases

Dianne Miller, C. Gilks, C. Gilks, 2003, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Immunohistochemistry and Next-generation Sequencing Are Complementary Tests in Identifying PTEN Abnormality in Endometrial Carcinoma Biopsies

M. Köbel, M. Jimenez-Linan, J. Brenton, 2020, medRxiv.

Poor Interobserver Reproducibility in the Diagnosis of High-grade Endometrial Carcinoma

C Blake Gilks, C. Gilks, C. Gilks, 2013, The American journal of surgical pathology.

Incidental Nonuterine High-grade Serous Carcinomas Arise in the Fallopian Tube in Most Cases: Further Evidence for the Tubal Origin of High-grade Serous Carcinomas

M. Köbel, C. Gilks, C. Gilks, 2015, The American journal of surgical pathology.

Interpretation of somatic POLE mutations in endometrial carcinoma

C. Gilks, M. McConechy, J. McAlpine, 2019, The Journal of pathology.

Classification of Extraovarian Implants in Patients With Ovarian Serous Borderline Tumors (Tumors of Low Malignant Potential) Based on Clinical Outcome

J. McKenney, S. Kalloger, C. Gilks, 2016, The American journal of surgical pathology.

Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas

C. Gilks, M. McConechy, J. McAlpine, 2019, The Journal of pathology.

Outcomes of Incidental Fallopian Tube High-Grade Serous Carcinoma and Serous Tubal Intraepithelial Carcinoma in Women at Low Risk of Hereditary Breast and Ovarian Cancer

A. Tinker, M. Köbel, C. Gilks, 2015, International Journal of Gynecologic Cancer.

Synchronous and metachronous endocervical and ovarian neoplasms: A different interpretation of HPV data [6]

Dianne Miller, C. Gilks, C. Gilks, 2005 .

Survey on Reporting of Endometrial Biopsies From Women on Progestogen Therapy for Endometrial Atypical Hyperplasia/Endometrioid Carcinoma

C. Gilks, R. Soslow, W. McCluggage, 2021, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Issues in the Differential Diagnosis of Uterine Low-grade Endometrioid Carcinoma, Including Mixed Endometrial Carcinomas: Recommendations from the International Society of Gynecological Pathologists

C. Gilks, C. Gilks, E. Oliva, 2018, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Combined CCNE1 high‐level amplification and overexpression is associated with unfavourable outcome in tubo‐ovarian high‐grade serous carcinoma

N. Le, K. Wiedemeyer, M. Köbel, 2020, The journal of pathology. Clinical research.

BRCA1 Immunohistochemical Staining as a Prognostic Indicator in Uterine Serous Carcinoma

P. Maxwell, S. Kalloger, C. Gilks, 2013, International Journal of Gynecologic Cancer.

Chemotherapy Response Score: Development and Validation of a System to Quantify Histopathologic Response to Neoadjuvant Chemotherapy in Tubo-Ovarian High-Grade Serous Carcinoma.

A. Tinker, N. Le, C. Gilks, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Data Set for the Reporting of Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma: Recommendations From the International Collaboration on Cancer Reporting (ICCR)

M. Köbel, C. Gilks, J. Ledermann, 2022, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists

C. Gilks, C. Gilks, E. Oliva, 2018, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Overexpression of the Anti-Adhesin Podocalyxin Is an Independent Predictor of Breast Cancer Progression

D. Huntsman, C. Gilks, L. Prentice, 2004, Cancer Research.

Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status

D. Huntsman, C. Gilks, M. McConechy, 2020, Modern Pathology.

Bi-allelic Dicer1 mutations in the gynecologic tract of mice drive lineage-specific development of DICER1 syndrome-associated cancer.

D. Huntsman, J. Senz, Winnie Yang, 2023, Cancer Research.

Protocol for the Examination of Specimens From Patients With Carcinoma of the Endometrium

C. Gilks, P. Branton, E. Oliva, 2009 .

p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies

M. Köbel, M. Jimenez-Linan, J. Brenton, 2019, The Journal of pathology.